Video Tutorials   |   Contact Us   |   Sign In   |   Join
News & Press: News

NAVTA and Zoetis, the makers of RIMADYL®, have partnered to launch a 3-part online CE* course

Friday, October 12, 2018   (0 Comments)
Share |

OA-NAVTA Press Release


NAVTA and Zoetis, the makers of RIMADYL® (carprofen), have partnered to launch a 3-part online CE* course to introduce the newly developed Canine Osteoarthritis (OA) Checklist - a tool designed specifically for veterinary technicians to facilitate collaboration with owners to identify and manage OA-related pain in their dogs.


As with many chronic conditions, the diagnosis and management of canine osteoarthritis (OA) requires a partnership between the pet owner and veterinary team. Module 1 of the Canine OA Pain Heroes Certification Course focuses on helping veterinary technicians familiarize themselves with OA pain in dogs, while giving them the tools to communicate this information to the pet owners. Having an effective strategy to gain insight into a dog’s behavior and activity at home is an invaluable first step to help the veterinary team screen for at-risk dogs. Module 2 introduces the idea of measuring metrics to better help treat canine OA. This is where the Zoetis Canine Osteoarthritis Checklist is introduced. An easy-to-use communication tool with validated parameters, the checklist is designed for veterinary technicians to use with pet owners as a first step in screening dogs for OA. While OA is a chronic disease for which there is no cure, effective management is key. Module 3 explores pain management using RIMADYL®(carprofen), and how to use the tools and techniques introduced in the previous two modules in a long-term OA pain management plan.


Module 1 of the Canine OA Pain Heroes Certification Course is now available at NAVTA’s CE portal, ce.navta.netDon’t forget to follow NAVTA on Facebook and Twitter to find out when Modules 2 and 3 launch.


IMPORTANT SAFETY INFORMATION: As a class, NSAIDS may be associated with gastrointestinal, kidney and liver side effects. These are usually mild, but may be serious. Pet owners should discontinue therapy and contact their veterinarian immediately if side effects occur. Evaluation for pre-existing conditions and regular monitoring are recommended for pets on any medication, including RIMADYL. Use with other NSAIDS or corticosteroids should be avoided. See full Prescribing Information.

*This program has been approved by AAVSB RACE for 1.5 hours of CE credit.

Powered by YourMembership  ::  Legal